PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-21.42%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-28.98%
Negative gross profit growth while AR is at 16.92%. Joel Greenblatt would examine cost competitiveness or demand decline.
-57.88%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-57.88%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
50.49%
Positive net income growth while AR is negative. John Neff might see a big relative performance advantage.
50.61%
Positive EPS growth while AR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
50.48%
Positive diluted EPS growth while AR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.27%
Share count expansion well above AR's 0.02%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
No Data
No Data available this quarter, please select a different quarter.
2.35%
Dividend growth of 2.35% while AR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-1.10%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
940.00%
Positive FCF growth while AR is negative. John Neff would see a strong competitive edge in net cash generation.
-63.78%
Negative 10Y revenue/share CAGR while AR stands at 184.93%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-37.08%
Negative 5Y CAGR while AR stands at 184.93%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-43.90%
Negative 3Y CAGR while AR stands at 184.93%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-84.61%
Negative 10Y OCF/share CAGR while AR stands at 49.17%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-57.43%
Negative 5Y OCF/share CAGR while AR is at 49.17%. Joel Greenblatt would question the firm’s operational model or cost structure.
-45.43%
Negative 3Y OCF/share CAGR while AR stands at 49.17%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-130.43%
Negative 10Y net income/share CAGR while AR is at 2214.70%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1172.56%
Negative 5Y net income/share CAGR while AR is 2214.70%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-568.09%
Negative 3Y CAGR while AR is 2214.70%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-54.65%
Negative equity/share CAGR over 10 years while AR stands at 232.87%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-68.92%
Negative 5Y equity/share growth while AR is at 232.87%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
1.71%
Below 50% of AR's 232.87%. Michael Burry suspects a serious short-term disadvantage in building book value.
-28.47%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-76.83%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-76.83%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
37.45%
AR growth well above AR's 17.52%. Michael Burry fears inflated revenue or higher default risk in the near future.
-26.47%
Inventory is declining while AR stands at 20.92%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-9.54%
Negative asset growth while AR invests at 4.26%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-8.46%
We have a declining book value while AR shows 2.46%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-10.00%
We’re deleveraging while AR stands at 6.85%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-7.63%
We cut SG&A while AR invests at 15.76%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.